Complications of soft tissue augmentation

Journal of Drugs in Dermatology

Volumn 7, Issue 9, 2008, Pages 841-845

  Hirsch, Ranella J ^a,b   Stier, Meghan ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Skincare Doctors   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; COLLAGEN; HYALURONIC ACID; HYDROXYAPATITE; LACTIC ACID; POLYLACTIC ACID; POLYMER;

ANIMAL; ARTICLE; CATTLE; CUTANEOUS PARAMETERS; ESTHETIC SURGERY; FACE; HUMAN; REJUVENATION;

ANIMALS; BIOCOMPATIBLE MATERIALS; CATTLE; COLLAGEN; COSMETIC TECHNIQUES; DURAPATITE; FACE; HUMANS; HYALURONIC ACID; LACTIC ACID; POLYMERS; REJUVENATION; SKIN AGING;

EID: 58249090514     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. de Maio M. Selection of patients. In: de Maio M. Injectable Fillers in Aesthetic Medicine. 1st ed. New York: Springer; 2006:11-15.
2. Lupo MP. Hyaluronic acid fillers in facial rejuvenation. Semin Cutan Med Surg. 2006;25:122-126. (Pubitemid 44572815)
3. Seeley BM, Denton AB, Ahn MS, Maas CS. Effect of homeopathic Arnica montana on bruising in face-lifts: results of a randomized, double-blind, placebo-controlled clinical trial. Arch Facial Plast Surg. 2006;8:54-59. (Pubitemid 44858709)
4. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg. 2006;118:92S-107S.
5. Ciocon JO, Ciocon DG, Galindo DJ. Dietary supplements in primary care. Botanicals can affect surgical outcomes and followup. Geriatrics. 2004;59:20-24. (Pubitemid 39244830)
6. Gladstone HB, Cohen JL. Adverse effects when injecting facial fillers. Semin Cutan Med Surg. 2007;26:34-39. (Pubitemid 46349783)
7. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29:588-595. (Pubitemid 36702442)
8. Berlin A, Cohen JL, Goldberg DJ. Calcium hydroxylapatite for facial rejuvenation. Semin Cutan Med Surg. 2006;25:132-137. (Pubitemid 44572810)
9. Roy D, Sadick N, Mangat D. Clinical trial of a novel filler material for soft tissue augmentation of the face containing synthetic calcium hydroxylapatite microspheres. Dermatol Surg. 2006;32:1134-1139. (Pubitemid 44370117)
10. Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg. 2006;118:46S-54S.
11. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: review. Dermatol Surg. 2005;31:1616-1625.
12. Douse-Dean T, Jacob CI. Fast and easy treatment for reduction of the Tyndall effect secondary to cosmetic use of hyaluronic acid. J Drugs Dermatol. 2008;7:281-283.
13. Lambros V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg. 2004;114:277. (Pubitemid 39195681)
14. Brody HJ. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg. 2005;31:893-897. (Pubitemid 44795682)
15. Hirsch RJ, Cohen J. Challenge: Correcting superficially placed hyaluronic acid. Skin and Aging. 2007;15:36-38.
16. Suhai B, Horvath G. How well does the Rayleigh model describe the E-vector distribution of skylight in clear and cloudy conditions? A full-sky polarimetric study. J Opt Soc Am A Opt Image Sci Vis. 2004;21:1669-1676.
17. Anderson RR. Rest azured? J Am Acad Dermatol. 2001;44:874-875.
18. Hirsch RJ, Narurkar V, Carruthers J. Management of injected hyaluronic acid induced Tyndall effects. Lasers Surg Med. 2006;38:202-204.
19. Rzany B, Zielke H. Complications. In: de Maio M, Rzany B. Injectable Fillers in Aesthetic Medicine. 1st ed. New York: Springer; 2006:67-77.
20. Beer KR. Radiesse nodule of the lips from a distant injection site: report of a case and consideration of etiology and management. J Drugs Dermatol. 2007;6:846-847.
21. Sadick NS, Katz BE, Roy D. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face. Dermatol Surg. 2007;33 (Suppl):S122-S127.
22. Cheng JT, Perkins SW, Hamilton MM. Collagen and injectable fillers. Otolaryngol Clin North Am. 2002;35:73-85. (Pubitemid 34111641)
23. Friedman PM, Mafong EA, Kauvar AN, Geronemus RG. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002;28:491-494. (Pubitemid 34686633)
24. Nathan N, Benrhaiem M, Lotfi H, et al. The role of hyaluronidase on lidocaine and bupivacaine pharmacokinetics after peribulbar blockade. Anesth Analg. 1996;82:1060-1064. (Pubitemid 26131043)
25. Dreizen NG, Framm L. Sudden unilateral visual loss after autologous fat injection into the glabellar area. Am J Ophthalmol. 1989;107:85-87. (Pubitemid 19028377)
26. Minning CA Jr. Hyaluronidase allergy simulating expulsive choroidal hemorrhage. Arch Ophthalmol. 1994;112:585-586.
27. Lowe NJ, Maxwell CA, Lowe P, et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol. 2001;45:930-933. (Pubitemid 33096637)
28. Senet P, Bachelez H, Ollivaud L, et al. Minocycline for the treatment of cutaneous silicone granulomas. Br J Dermatol. 1999;140:985-987. (Pubitemid 29238494)
29. Edwards PC, Fantasia JE, Iovino R. Foreign body reaction to hyaluronic acid (Restylane): an adverse outcome of lip augmentation. J Oral Maxillofac Surg. 2006;64:1296-1299. (Pubitemid 44056330)
30. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg. 2007;33 (Suppl):S168-S175. (Pubitemid 350233456)
31. Toy BR, Frank PJ. Outbreak of Mycobacterium abscessus infection after soft tissue augmentation. Dermatol Surg. 2003;29:971-973. (Pubitemid 37087458)
32. Coleman SR. Avoidance of arterial occlusion from injectable fillers. Aesthetic Surg J. 2002;22:555.
33. Schanz S, Schippert W, Ulmer A, et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol. 2002;146:928-929. (Pubitemid 34539217)
34. Hirsch RJ, Cohen JL, Carruthers JD. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg. 2007;33:357-360. (Pubitemid 46328237)
35. Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol Surg. 2006;32:276-281.
36. Hirsch RJ, Lupo M, Cohen JL, Duffy D. Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase. J Drugs Dermatol. 2007;6:325-328.